NCT01380548

Effects of 5-Aminolevulinic Acid on Iron Deficiency Anemia

A Double-blind, Placebo Controlled Study to Assess Efficacy of 5-Aminolevulinic Acid in Subjects With Iron Deficiency Anemia

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 135 (estimated)
• Sponsor: Hiroshima University · Academic / Other
• Sex: Female
• Age: 20 Years – 49 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to evaluate efficacy and dose-dependency of 5-aminolevulinic acid in subjects with iron deficiency anemia.

Conditions

• Iron Deficiency Anemia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Placebo	Placebo; once/day; for 12 weeks
DIETARY_SUPPLEMENT	Iron alone	Iron (3 mg); once/day; for 12 weeks
DIETARY_SUPPLEMENT	Low-dose 5-aminolevulinic acid with iron	5-Aminolevulinic acid (12.5 mg) and iron (3 mg); once/day; for 12 weeks
DIETARY_SUPPLEMENT	Medium-dose 5-aminolevulinic acid with iron	5-Aminolevulinic acid (25 mg) and iron (3 mg); once/day; for 12 weeks
DIETARY_SUPPLEMENT	High-dose 5-aminolevulinic acid with iron	5-Aminolevulinic acid (50 mg) and iron (3 mg); once/day; for 12 weeks

Timeline

• Start date: 2011-06-01
• Primary completion: 2012-12-01
• Completion: 2012-12-01
• First posted: 2011-06-27
• Last updated: 2013-03-28

Locations

1 site across 1 country: Japan